發(fā)布時間：2018-11-15 11:56

【摘要】：目的:探討銀屑膠囊聯合復方氟米松軟膏治療尋常型銀屑病的臨床效果及安全性。方法:將66例尋常型銀屑病患者按隨機數字表法分為對照組和觀察組,各33例。兩組患者均局部外用復方氟米松軟膏適量,bid;在此基礎上,觀察組患者加服銀屑膠囊,每次1.35 g,tid。兩組均治療8周。比較兩組患者治療前后的銀屑病皮損面積和嚴重程度指數(PASI)評分、皮膚病生活質量指數(DLQI)評分、血清炎癥細胞因子水平,觀察其臨床療效和不良反應發(fā)生情況。結果:治療后,兩組患者PASI評分與DLQI評分均較治療前明顯降低,且觀察組患者明顯低于對照組,差異均有統計學意義(P0.05)。觀察組患者的有效率(84.85%)明顯高于對照組(63.64%),差異有統計學意義(P0.05)。兩組患者血清IL-8、TNF-α、VEGF水平均較治療前明顯降低,且觀察組患者明顯低于對照組,差異均有統計學意義(P0.05)。兩組患者不良反應發(fā)生率比較,差異無統計學意義(P0.05)。結論:銀屑膠囊治療尋常型銀屑病可通過降低患者血清IL-8、TNF-α、VEGF等炎癥細胞因子水平發(fā)揮確切的療效,且安全性較好。
[Abstract]:Objective: to investigate the clinical effect and safety of Yinshi capsule combined with compound flumisone ointment in the treatment of psoriasis vulgaris. Methods: 66 patients with psoriasis vulgaris were randomly divided into control group (n = 33) and observation group (n = 33). The patients in both groups were treated with compound flumisone ointment with proper amount, and the patients in the observation group were given silver chip capsule at a dose of 1.35 g / d on the basis of bid;. Both groups were treated for 8 weeks. The area and severity of psoriasis before and after treatment were compared between the two groups. The (PASI) score, the (DLQI) score of skin disease quality of life index and the level of serum inflammatory cytokines were compared between the two groups, and the clinical efficacy and adverse reactions were observed. Results: after treatment, the PASI score and DLQI score of the two groups were significantly lower than those before treatment, and the observation group was significantly lower than the control group, the difference was statistically significant (P0.05). The effective rate of the observation group (84.85%) was significantly higher than that of the control group (63.64%), the difference was statistically significant (P0.05). The serum levels of IL-8,TNF- 偽 and VEGF in the two groups were significantly lower than those before treatment, and the levels of serum IL-8,TNF- 偽 and VEGF in the observation group were significantly lower than those in the control group (P0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P0.05). Conclusion: Yinfeng capsule can play an effective role in treating psoriasis vulgaris by lowering the levels of inflammatory cytokines such as IL-8,TNF- 偽, VEGF and so on.
【作者單位】： 牡丹江醫(yī)學院紅旗醫(yī)院皮膚科;
【分類號】：R758.63

【相似文獻】

相關會議論文 前10條

1 刁慶春;柯丹;陳德宇;向光;劉濤;黎斌;薛梅;向進;呂靜;張潔;;復方氟米松軟膏治療尋常型銀屑病有效性與安全性評價[A];2010全國中西醫(yī)結合皮膚性病學術會議論文匯編[C];2010年

2 柯丹;刁慶春;薛梅;呂靜;張潔;;復方氟米松軟膏治療神經性皮炎臨床觀察[A];2009全國中西醫(yī)結合皮膚性病學術會議論文匯編[C];2009年

3 柯丹;刁慶春;伍津津;李建軍;薛梅;呂靜;張潔;代紹珍;樊華;;復方氟米松軟膏治療神經性皮炎臨床療效和安全性評價[A];2010全國中西醫(yī)結合皮膚性病學術會議論文匯編[C];2010年

4 柯丹;刁慶春;伍津津;李建軍;薛梅;呂靜;張潔;代紹珍;樊華;;復方氟米松軟膏治療神經性皮炎臨床療效和安全性評價[A];中華中醫(yī)藥學會皮膚科分會第七次學術年會、2010年重慶四川中西醫(yī)結合皮膚性病學術年會、全國中西醫(yī)結合診療皮膚性病新進展新技術學習班論文匯編[C];2010年

5 皮超;梁渝珩;高鵑;王鴻健;;308nm準分子光聯合復方氟米松軟膏治療神經性皮炎的療效觀察[A];2014全國中西醫(yī)結合皮膚性病學術年會論文匯編[C];2014年

6 趙俊文;左衛(wèi)堂;田景嬋;吳錦葵;何育華;;潤燥止癢膠囊聯合復方氟米松軟膏治療老年性慢性角化性濕疹臨床觀察[A];2013全國中西醫(yī)結合皮膚性病學術年會論文匯編[C];2013年

7 張丹莉;史萍;;復方氟米松軟膏聯合黃連膏治療手部濕疹療效觀察[A];中華中醫(yī)藥學會皮膚科分會第六次學術年會、趙炳南學術思想研討會、全國皮膚科中醫(yī)外治高級研修班論文集[C];2009年

8 李蓮花;;復方氟米松軟膏治療皮炎濕疹療效觀察[A];中華醫(yī)學會第十八次全國皮膚性病學術年會論文匯編[C];2012年

9 蘭巖菊;宋欣;余新民;;復方氟米松軟膏聯合消炎生肌膏治療掌跖角化性濕疹臨床觀察[A];2012年浙江省皮膚病性病學術會議論文集[C];2012年

10 劉洪普;劉翠杰;;復方氟米松軟膏與重樓解毒酊聯合外用治療局限性慢性濕疹[A];2009全國中西醫(yī)結合皮膚性病學術會議論文匯編[C];2009年

相關碩士學位論文 前1條

1 李鴻國;復方氟米松軟膏治療慢性濕疹臨床觀察及實驗研究[D];大連醫(yī)科大學;2009年

，

本文編號：2333242